The IPO Buzz: Scribe Therapeutics Prices IPO at $15 – High End – & Stock Pops Almost 67 Percent
Scribe Therapeutics (SCTX) upsized its IPO at pricing to 8.58 million shares – up from 7.15 million in the prospectus – and priced the deal at $15.00 – the top of its range – to raise $128.7 million on Thursday night, July 23, 2026. Scribe’s stock jumped nearly 67 percent – opening at $25.00 – […]
July 23, 2026 Read More